The Bull Case For United Therapeutics (UTHR) Could Change Following FDA RMAT Status For miroliverELAP [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
miroliverELAP external liver assist product, which uses a bioengineered liver to provide temporary support for acute liver failure patients and is still not approved anywhere. This RMAT status underscores regulatory interest in United Therapeutics' broader organ-manufacturing efforts across hearts, kidneys, livers, and lungs, highlighting how its bioengineered platforms could help address the persistent shortage of transplantable organs. We'll now examine how the FDA's RMAT designation for miroliverELAP fits into and potentially reshapes United Therapeutics' investment narrative. Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow. United Therapeutics Investment Narrative Recap To own United Therapeutics, you need to believe its pulmonary therapies can keep funding a long runway of high risk, high reward organ manufacturing projects. The RMAT designat
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026 [Yahoo! Finance]Yahoo! Finance
- United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026Business Wire
- Groundbreaking Meeting of Minds at Northwell Health's Quantum Biology Forum Unlocks New Understanding of Life's Fundamental Principles [Yahoo! Finance]Yahoo! Finance
- 3 Reasons Investors Love United Therapeutics (UTHR) [Yahoo! Finance]Yahoo! Finance
- United Therapeutics (UTHR) was upgraded by Raymond James Financial, Inc. to "moderate buy".MarketBeat
UTHR
Earnings
- 10/29/25 - Beat
UTHR
Sec Filings
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- UTHR's page on the SEC website